Second Symposium on Translational Genomics

March 15-16, 2012
Natcher Auditorium, NIH Bethesda
REGISTER NOW!

National Cancer Institute Symposium on Integrative Cancer Biology and
Genomics: Second Symposium on Translational Genomics

The field of translational genomics is rapidly progressing, yet the
systematic application of current knowledge to improve patient care remains
a formidable challenge. This symposium will provide a dedicated forum for
the advancement, implementation and exchange of information on noncoding
RNAs, next generation sequencing, and epigenomics and genetic variation for
translation into clinical practice with the ultimate goal to improve the
health of patients with cancer.

Organizing Committee: Laufey Amundadottir, Curt Harris, Tim Harris, Javed
Khan, Glenn Merlino, Thomas Ried, and Snorri Thorgeirsson

Topics include:
•       Noncoding RNAs: The Dark Matter of the Genome
•       Next Generation Sequencing for Next Generation Medicine
•       Epigenomics and genetic variation

Speakers include:
Eric Green, NHGRI * David Goldstein, Duke University * Joshua Mendell, UT
Southwestern Medical Center * Joanne Weidhaas, Yale University * Curt
Harris, NCI * Natasha Caplen, NCI * Carlo Croce, Ohio State University *
Barbara Wold, California Institute of Technology * Tim Harris, Biogen Idec
* David Ting, Massachusetts General Hospital * Elaine Mardis, Washington
University * Steve Lincoln, Complete Genomics * Javed Khan, NCI * Manel
Esteller, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona *
Peter Jones, University of Southern California * Jean-Pierre Issa, Temple
University School of Medicine * Paul Meltzer, NCI * Olofumni Olopade,
University Of Chicago * Laufey Amundadottir, NCI

To Register: Registration is free but seating is limited so please register
online at: <http://web.ncifcrf.gov/events/TranslationalGenomics/register.asp
>

For additional information please contact Laura Hooper at
hooperl@mail.nih.gov

	[[alternative HTML version deleted]]

